Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-37.92M
↓ 46% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-26.05M
Historical baseline
PeriodValueYoY Change
TTM$-37.92M-0.6%
2024$-37.69M-22.0%
2023$-30.89M+8.7%
2022$-33.82M-46.8%
2021$-23.04M-41.2%
2020$-16.32M-23.0%
2019$-13.27M-0.5%
2018$-13.20M+43.3%
2017$-23.28M+25.0%
2016$-31.04M-